Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion,Clinical Respiratory Journal

当前位置： X-MOL 学术 › Clin. Respir. J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion
Clinical Respiratory Journal ( IF 1.7 ) Pub Date : 2023-09-18 , DOI: 10.1111/crj.13700
Tianyuan Li ₁ , Panwen Tian ₁ , Qin Huang ₁ , Hao Zeng ₂ , Qi Wei ₂ , Yalun Li ₁

Affiliation

Patients with malignant pleural effusion (MPE) typically have poor prognoses, and predicting survival is challenging. The present study aimed to identify prognostic factors of overall survival (OS) in non-small cell lung cancer (NSCLC) patients with MPE in the time of immunotherapy and targeted therapy.

中文翻译：